1Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis, 2002, 34: 7-14.
4Bohme A, Ruhnke M, Buchheidt D, et al. Treatment of fungal infections in hematology and oncology-guidelines of the Infectious Diseases Working Party (AG1HO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol, 2003, 82 Suppl 2 :S133-S140.
3Gratwohl A, Brand R, Frassoni F, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infections complications and changes over calendar time. Bone Marrow Transplant, 2005, 36:757-769.
4Ninin E,Milpied N,Morean P,et al.Longitudinal study of bacterial,viral,and fungnl infections in adult recipients of bone marrow transplants.Clin Infect Dis,2001,33:41-47.
